<DOC>
	<DOCNO>NCT02131480</DOCNO>
	<brief_summary>Uterine leiomyosarcoma soft tissue rare tumor poor prognosis metastatic locally advance . They average chemosensitivity mainly doxorubicin , ifosfamide , cisplatin , gemcitabine trabectedin response rate combination first line exceed 55 % uterine leiomyosarcomas 35 % leiomyosarcomas soft tissue . The trabectedin new cancer drug obtain marketing authorization failure anthracyclines ifosfamide treatment soft tissue sarcoma ( STM ) Europe . It especially show efficacy myxoid liposarcoma , leiomyosarcomas synoviosarcoma . This study aim evaluate usefulness combination trabectedin doxorubicin first-line treatment uterine soft tissue leiomyosarcoma .</brief_summary>
	<brief_title>Study Doxorubicin Trabectedin First Line Treatment Patients With Metastatic Leiomyosarcoma</brief_title>
	<detailed_description />
	<mesh_term>Leiomyosarcoma</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Trabectedin</mesh_term>
	<criteria>Metastatic leiomyosarcoma ( uterus soft tissue ) inoperable relapse previous chemotherapy At least one measurable lesion accord RECIST criterion inclusion . At least one target none irradiated area Aged &gt; /= 18 year physiological age &lt; /= 70 year PS &lt; /= 2 Normal hematological function ( Polymorphonuclear Neutrophils &gt; /= 1500/mm3 , platelet &gt; /= 100 000/mm3 ) Normal kidney function ( creatinine &lt; 1.5xN ) Creatinine phosphokinase &lt; /= 2.5xN Normal hepatic function ( total bilirubin &lt; /= 1xN ; transaminase &lt; /= 2.5xN alkaline phosphatase &lt; /= 1.5xN ) Cardiac function : normal echography and/or isotopic ventriculography ( FR &gt; 30 % , FEVG &gt; 50 % ) Patients able procreate must use birth control device treatment 3 month treatment woman ; 5 month men Signed informed consent Patient affiliate system care Any histological type uterus sarcoma ( carcinosarcoma ... ) soft tissue Specific contraindication treatment Previous evolutive mental disease Previous cancer Symptomatic know brain metastasis Previous radiotherapy ont measurable lesion Previous allograft autograft Known positive serology ( HIV , HbC , HbS ) Pregnant breastfeed woman Impossibility follow treatment geographical , social mental reason Patients legal protection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>